(Q53641005)

16 May 2018

title

Multilineage involvement of the fusion gene in patients with FIP1L1/PDGFRA-positive hypereosinophilic syndrome. (English)

1 reference

16 May 2018

0 references

1 reference

16 May 2018

Amy D. Klion

1 reference

16 May 2018

Svetlana Pack

0 references

Thomas B Nutman

1 reference

16 May 2018

Yae-Jean Kim

object named as

Yae-Jean Kim

1 reference

16 May 2018

author name string

Jamie Robyn

1 reference

16 May 2018

Steven Lemery

1 reference

16 May 2018

J Philip McCoy

1 reference

16 May 2018

Joseph Kubofcik

1 reference

16 May 2018

language of work or name

English

0 references

publication date

1 February 2006

1 reference

16 May 2018

British Journal of Haematology

published in

1 reference

16 May 2018

volume

132

1 reference

16 May 2018

issue

1 reference

16 May 2018

page(s)

286-292

1 reference

16 May 2018

A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05863.X

PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05863.X

The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05863.X

Mast cells, basophils, and eosinophils acquire constitutive IL-4 and IL-13 transcripts during lineage differentiation that are sufficient for rapid cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05863.X

FIP1L1-PDGFRalpha in hypereosinophilic syndrome and mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05863.X

The FIP1L1-PDGFRalpha fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05863.X

Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05863.X

Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05863.X

Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05863.X

GATA-1 as a regulator of mast cell differentiation revealed by the phenotype of the GATA-1low mouse mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05863.X

Heterogeneity of response to imatinib-mesylate (glivec) in patients with hypereosinophilic syndrome: implications for dosing and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05863.X

FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05863.X

Clonal development of myeloproliferative disorders: clues to hematopoietic differentiation and multistep pathogenesis of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05863.X

Both B and T lymphocytes may be clonally involved in myelofibrosis with myeloid metaplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05863.X

The chronic myeloproliferative disorders: clonality and clinical heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05863.X

Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05863.X

Confidence interval estimation of the intraclass correlation coefficient for binary outcome data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05863.X

10.1111/J.1365-2141.2005.05863.X

21 January 2018

Identifiers

DOI

1 reference

16 May 2018

release_hspi4wxzsjdydcnccoqxs6wqlq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hspi4wxzsjdydcnccoqxs6wqlq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

16 May 2018